BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 25086257)

  • 61. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.
    Friberg L; Tabrizi F; Englund A
    Eur Heart J; 2016 Aug; 37(31):2478-87. PubMed ID: 26984861
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
    Cappato R; Marchlinski FE; Hohnloser SH; Naccarelli GV; Xiang J; Wilber DJ; Ma CS; Hess S; Wells DS; Juang G; Vijgen J; Hügl BJ; Balasubramaniam R; De Chillou C; Davies DW; Fields LE; Natale A;
    Eur Heart J; 2015 Jul; 36(28):1805-11. PubMed ID: 25975659
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry.
    Nührich JM; Kuck KH; Andresen D; Steven D; Spitzer SG; Hoffmann E; Schumacher B; Eckardt L; Brachmann J; Lewalter T; Hochadel M; Senges J; Willems S; Hoffmann BA
    Clin Res Cardiol; 2015 Jun; 104(6):463-70. PubMed ID: 25537233
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.
    Efremidis M; Vlachos K; Letsas KP; Giannopoulos G; Lioni L; Georgopoulos S; Vadiaka M; Deftereos S; Sideris A
    J Electrocardiol; 2015; 48(5):840-4. PubMed ID: 26152604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term incidence and predictive factors of thromboembolic events after a cryoballoon ablation for atrial fibrillation.
    Hermida A; Zaitouni M; Diouf M; Lallemand PM; Fay F; Buiciuc O; Kubala M; Hermida JS
    Int J Cardiol; 2020 Dec; 321():99-103. PubMed ID: 32810541
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Temporal trends of in-hospital complications associated with catheter ablation of atrial fibrillation in the United States: An update from Nationwide Inpatient Sample database (2011-2014).
    Tripathi B; Arora S; Kumar V; Abdelrahman M; Lahewala S; Dave M; Shah M; Tan B; Savani S; Badheka A; Gopalan R; Shantha GPS; Viles-Gonzalez J; Deshmukh A
    J Cardiovasc Electrophysiol; 2018 May; 29(5):715-724. PubMed ID: 29478273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
    Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.
    Da Costa A; Ben H'dech M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(8-9):423-32. PubMed ID: 23906679
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Periprocedural anticoagulation for atrial fibrillation ablation.
    Mortada ME; Chandrasekaran K; Nangia V; Dhala A; Blanck Z; Cooley R; Bhatia A; Gilbert C; Akhtar M; Sra J
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):362-6. PubMed ID: 18284509
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prolonged atrium electromechanical interval is associated with stroke in patients with atrial fibrillation after catheter ablation.
    Chao TF; Lin YJ; Tsao HM; Chang SL; Lo LW; Hu YF; Tuan TC; Li CH; Chang HY; Wu TJ; Yu WC; Chen SA
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):375-80. PubMed ID: 23252831
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors.
    Zuern CS; Kilias A; Berlitz P; Seizer P; Gramlich M; Müller K; Duckheim M; Gawaz M; Schreieck J
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):688-93. PubMed ID: 25753968
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation.
    Szegedi N; Széplaki G; Herczeg S; Tahin T; Salló Z; Nagy VK; Osztheimer I; Özcan EE; Merkely B; Gellér L
    Europace; 2019 May; 21(5):732-737. PubMed ID: 30689857
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidental LV LGE on CMR Imaging in Atrial Fibrillation Predicts Recurrence After Ablation Therapy.
    Suksaranjit P; Akoum N; Kholmovski EG; Stoddard GJ; Chang L; Damal K; Velagapudi K; Rassa A; Bieging E; Challa S; Haider I; Marrouche NF; McGann CJ; Wilson BD
    JACC Cardiovasc Imaging; 2015 Jul; 8(7):793-800. PubMed ID: 26093929
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Asymptomatic Pulmonary Embolism after Ablation.
    Guler GB; Can MM; Guler E; Akinci T; Sogukpinar O; Hatipoglu S; Kilicaslan F; Serebruany VL
    Cardiology; 2016; 134(4):426-32. PubMed ID: 27144590
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictors of atrial fibrillation termination and clinical success of catheter ablation of persistent atrial fibrillation.
    Heist EK; Chalhoub F; Barrett C; Danik S; Ruskin JN; Mansour M
    Am J Cardiol; 2012 Aug; 110(4):545-51. PubMed ID: 22591670
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical outcomes of bridging therapy with fondaparinux versus low-molecular-weight heparin in patients undergoing atrial fibrillation ablation.
    Zhang F; Zhao D; Peng X; Yang H; Zhu T; Huang F; Peng J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):448-52. PubMed ID: 24752085
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation.
    Gersak B; Pernat A; Robic B; Sinkovec M
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1059-66. PubMed ID: 22587585
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of dense "smoke" detected on transesophageal echocardiography on stroke risk in patients with atrial fibrillation undergoing catheter ablation.
    Gedikli Ö; Mohanty S; Trivedi C; Gianni C; Chen Q; Della Rocca DG; Burkhardt JD; Sanchez JE; Hranitzky P; Gallinghouse GJ; Al-Ahmad A; Horton R; Di Biase L; Natale A
    Heart Rhythm; 2019 Mar; 16(3):351-357. PubMed ID: 30312757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.